U.S., July 17 -- ClinicalTrials.gov registry received information related to the study (NCT07068425) titled 'Longitudinal Observational Study on Immune Thrombocytopenia' on July 06.
Brief Summary: Immune Thrombocytopenia (ITP) is a bleeding disorder characterized by immune-mediated destruction and/or impaired production of platelets, leading to clinical manifestations such as petechiae, purpura, mucosal bleeding, and in severe cases, life-threatening visceral or intracranial hemorrhage. Research on the diagnosis, treatment, and prognosis of ITP is critical for improving patient outcomes and quality of life. However, most existing hematologic cohort studies are limited to single-center or small multicenter samples, lacking comprehensive, la...